Webinars on demand

With the emergence of a new class of targeted precision oncology therapies, NTRK fusions are increasingly becoming biomarkers that pathology laboratories can test for in FFPE tumor tissue.

Join editor Michael Schubert, along with representatives from Proscia and Hamamatsu, in this educational webinar that explains the growing need for pathologists to collaborate remotely.

As part of the College’s International Pathology Day (IPD) celebrations, the College has partnered with The Pathologist to host this one-day event.

After the transition of our pathology lab to a fully digital workflow, we began setting up new, more accurate workflow analyses.

In this webinar, Albrecht Stenzinger will discuss the principles of using nextgeneration sequencing (NGS) to identify the number of genetic alterations in a tumor.

This webinar is a “must see” for anyone interested in PD-1/PD-L1 targeted immunotherapy and quantitative methods for biomarker assessment in immuno-oncology.

Dr. Campbell presents results from a study of DCIS patients receiving neoadjuvant treatment with pembrolizumab, injected directly into lesions

In this webinar Dr. Parwani will discuss how he and his team are continuing to work towards a “slideless” workflow.

Join Leica Biosystems and Proscia Digital Pathology as they discuss why institutions are going digital today and how they approach best practices in digital implementation.

Join Leica Biosystems and Proscia Digital Pathology as they discuss why institutions are going digital today and how they approach best practices in digital implementation.

The Pathologist and Thermo Fisher Scientific are giving you the opportunity to delve into tumour mutation burden.

Cancer care has evolved over time to precise, targeted & personalized therapy options. This evolution is primarily fueled by molecular pathology, which is now under pressure from increasing tests and a shortage of pathologists.